Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.7 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |